Posters presented at the Association of Cancer Care Centers opening session covered initiatives to boost clinical trial ...

The audited financial statements for the year ended December 31, 2024 included in the Company's Annual Report on Form 10-K ...

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ...

In this interview, Professor Ted Dinan, Medical Director at Atlantia Clinical Trials, and Asa Waldstein, Principal at ...

Promising multiple dose PK data continue to support 4-weekly dosingFDA advice received supporting phase 2 design in HSStrong Key Opinion ...

Mind Medicine (MindMed) Inc. ( NASDAQ: MNMD) Q4 2024 Earnings Conference Call March 6, 2025 8:00 AM ET Stephanie Fagan - Chief Corporate Affairs Officer Rob Barrow - CEO Dan Karlin - CMO ...

Project Optimus seeks to transform how doses are selected and optimised in oncology drug development. As this initiative ...

A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...

Post-authorisation safety studies (PASS) are often seen simply as a regulatory necessity, a checkbox that ensures ongoing ...

A new study reveals concerning risks associated with tattoos, including higher rates of lymphoma and skin cancer.

In February 2024 a putative class action complaint against Molecular Partners, its directors, and certain of its executive officers, originally filed in July 2022 in the U.S. District Court for the ...

U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...